BiotechTube
Home/Investors/Fidelity

Fidelity

Biotech Investor · 4 portfolio companies

Portfolio
4
Combined Value
$10.3B
Focus Areas
8
Top Stage
Phase 3

Investment Focus

Neuromuscular DisordersOncologyFibrosisNeurodegenerative DiseasesLysosomal Storage DisordersCentral Nervous System (CNS)Solid TumorsImmunology

Portfolio Companies

CompanyValuation
Scholar Rock Holding$5.2B
Denali Therapeutics$3.3B
Bicara Therapeutics$1.2B
Eikon Therapeutics$563.6M

Frequent Co-Investors

Atlas Venture2 sharedThe Column Group2 sharedPublic shareholders1 sharedArch Venture Partners1 sharedEcoR1 Capital1 sharedOther institutional and public shareholders1 sharedMedicxi1 sharedRA Capital Management1 shared